Clinical inquiries. What are the best prophylactic drugs for migraine?
Firnhaber
Jonathon M
JM
Brody School of Medicine at East Carolina University, Greenville, NC, USA.
Rickett
Katherine
K
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000639:Amitriptyline / Q000008:administration & dosage; D019317:Evidence-Based Medicine; D005194:Family Practice / Q000592:standards / Q000639:trends; D005260:Female; D005632:Fructose / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D010147:Pain Measurement; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011433:Propranolol / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D012720:Severity of Illness Index; D013999:Timolol / Q000008:administration & dosage; D000077236:Topiramate; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D018696:Neuroprotective Agents; D000077236:Topiramate; D000639:Amitriptyline; D005632:Fructose; D013999:Timolol; D011433:Propranolol